CPMD — Cannapharmarx Income Statement
0.000.00%
Last trade - 00:00- $2.51m
- $17.13m
- $1.36m
Annual income statement for Cannapharmarx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.82 | 1.36 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | -1.05 | -0.404 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.5 | 6.14 | -5.23 | 5.12 | 9.23 |
| Operating Profit | -10.5 | -6.14 | 5.23 | -4.3 | -7.87 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.83 | -8.53 | 3.69 | -9.91 | -11.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -8.83 | -8.53 | 3.69 | -9.91 | -11.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.83 | -8.53 | 3.69 | -9.91 | -11.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.83 | -8.53 | 3.69 | -9.91 | -11.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.013 | -0.036 | -0.01 | -0.012 | -0.007 |